Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-102696
Filing Date
2014-03-17
Accepted
2014-03-17 17:24:27
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d652768d10k.htm 10-K 955100
2 EX-23.1 d652768dex231.htm EX-23.1 1898
3 EX-31.1 d652768dex311.htm EX-31.1 6612
4 EX-31.2 d652768dex312.htm EX-31.2 6714
5 EX-32.1 d652768dex321.htm EX-32.1 3585
6 EX-32.2 d652768dex322.htm EX-32.2 3569
  Complete submission text file 0001193125-14-102696.txt   9307129

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT isco-20131231.xml EX-101.INS 1220847
8 XBRL TAXONOMY EXTENSION SCHEMA isco-20131231.xsd EX-101.SCH 86102
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20131231_cal.xml EX-101.CAL 76691
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20131231_def.xml EX-101.DEF 346013
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20131231_lab.xml EX-101.LAB 638669
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20131231_pre.xml EX-101.PRE 517816
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

EIN.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51891 | Film No.: 14698534
SIC: 2834 Pharmaceutical Preparations